Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H&T Presspart is a leading global manufacturer of drug delivery devices and components, specializing in respiratory healthcare. The company provides a comprehensive range of metered-dose inhaler (MDI) canisters, actuators, and dry powder inhalers for the pharmaceutical industry. With a focus on innovation, H&T Presspart offers advanced surface treatment technologies like the Plasma Edition to improve drug stability and delivery. They also develop digital health solutions, including connected inhalers designed to enhance patient adherence and provide real-time data. As a contract manufacturing partner, they support pharmaceutical companies from initial design and prototyping through to large-scale commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H&T.